Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME)

CompletedOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

July 31, 2014

Study Completion Date

September 30, 2017

Conditions
Coronary Artery Disease
Trial Locations (29)

Unknown

Hallym University Sacred Heart Hospital, Anyang

Soonchunhyang Univ. Bucheon Hospital, Bucheon-si

Soon Chun Hyang University Hospital Cheonan, Cheonan

Gangwon National Univ. Hospital, Chuncheon

Daegu Catholic University Medical Center, Daegu

Keimyung University Dongsan Medical Center, Daegu

The Catholic University of Korea, Daejeon ST. Mary's Hospital, Daejeon

Gangneung Asan Hospital, Gangneung

Chonnam National University Hospital, Gwangju

National Health Insurance Corporation Ilsan Hospital, Ilsan

Presbyterian Medical Center, Jeonju

Gyeongsang National University Hospital, Jinju

Kwangju Christian Hospital, Kwangju

Inje University Pusan Paik Hospital, Pusan

Pusan National University Hospital, Pusan

Pusan National University Yangsan Hospital, Pusan

Bundang Cha Medical Center, Seongnam

Asan Medical Center, Seoul

Gangnam Severance Hospital, Seoul

Kangnam Sacred Heart Hospital, Seoul

Korea University Anam Hospital, Seoul

Korea University Guro Hospital, Seoul

Kyunghee University Hospital at Gangdong, Seoul

The Catholic University of Korea Seoul St. Mary's Hospital, Seoul

The Catholic University of Korea, Yeouido St. Mary's Hospital, Seoul

St.carollo Hospital, Suncheon

The Catholic University of Korea St. Vincent's Hospital, Suwon

The Catholic University of Korea Uijeongbu St. Mary's Hospital, Uijeongbu-si

Ulsan University Hospital, Ulsan

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

CardioVascular Research Foundation, Korea

OTHER

collaborator

Abbott

INDUSTRY

lead

Seung-Jung Park

OTHER